Skip to main content
OpenTrials

Clinical trial condition

Malformations of Cortical Development

Explore clinical trials studying Malformations of Cortical Development. Study availability and eligibility vary by location and protocol.

127 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Malformations of Cortical Development trial results

Completed

Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B)

NCT04285346

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +12 more
Locations
  • Marinus Research Site Los Angeles, California, United States
  • Marinus Research Site Palo Alto, California, United States
  • Marinus Research Site Boston, Massachusetts, United States
  • Marinus Research Site Livingston, New Jersey, United States
View Trial Details
Completed

A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

NCT02544763

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +17 more
Locations
  • UAB Epilepsy Center Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UCLA-Pediatric Neurology Los Angeles, California, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
View all 44 locations
View Trial Details
Completed

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

NCT00126672

Conditions
Angiomyolipoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
Locations
  • Loma Linda University School of Medicine Loma Linda, California, United States
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • New York University Medical Center New York, United States
View Trial Details
Completed

Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.

NCT03525834

Conditions
Angiomyolipoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +26 more
Locations
  • Novartis Investigative Site Wuhan, Hubei, China
  • Novartis Investigative Site Shanghai, Shanghai Municipality, China
  • Novartis Investigative Site Chengdu, Sichuan, China
  • Novartis Investigative Site Beijing, China
View Trial Details

Related conditions